273 related articles for article (PubMed ID: 18624999)
1. The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO).
Alevizaki M; Mantzou E; Cimponeriu A; Saltiki K; Philippou G; Wiersinga W
Clin Endocrinol (Oxf); 2009 Mar; 70(3):464-8. PubMed ID: 18624999
[TBL] [Abstract][Full Text] [Related]
2. [The relevance of tumor necrosis factor-alpha gene-863C/A polymorphism with thyroid-associated ophthalmopathy].
Yan SL; Wang YX
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):786-90. PubMed ID: 16191343
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Pro12Ala polymorphism of the PPAR gamma 2 gene on response to pioglitazone treatment in menopausal women.
Ramírez-Salazar M; Pérez-Luque E; Fajardo-Araujo M; Garza SM; Malacara JM
Menopause; 2008; 15(6):1151-6. PubMed ID: 18551086
[TBL] [Abstract][Full Text] [Related]
4. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
5. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta gene (IL-1beta) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population.
Lacka K; Paradowska A; Gasinska T; Soszynska J; Wichary H; Kramer L; Lacki JK
Curr Eye Res; 2009 Mar; 34(3):215-20. PubMed ID: 19274529
[TBL] [Abstract][Full Text] [Related]
7. [Concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients witt Graves' disease and thyroid associated orbitopathy].
Kulig G; Pilarska K; Kulig J
Przegl Lek; 2004; 61(12):1319-24. PubMed ID: 15850321
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
9. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
Stefański A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Moleda P; Pilarska K
J Hum Hypertens; 2006 Sep; 20(9):684-92. PubMed ID: 16625233
[TBL] [Abstract][Full Text] [Related]
10. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
[TBL] [Abstract][Full Text] [Related]
11. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population.
Yang LL; Hua Q; Liu RK; Yang Z
Arch Med Res; 2009 Feb; 40(2):89-96. PubMed ID: 19237017
[TBL] [Abstract][Full Text] [Related]
12. Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy.
Daumerie Ch; Duprez T; Boschi A
Eur J Intern Med; 2008 Nov; 19(7):531-6. PubMed ID: 19013383
[TBL] [Abstract][Full Text] [Related]
13. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
[TBL] [Abstract][Full Text] [Related]
14. PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease.
Pawlak-Adamska E; Daroszewski J; Bolanowski M; Oficjalska J; Janusz P; Szalinski M; Frydecka I
Immunogenetics; 2013 Jul; 65(7):493-500. PubMed ID: 23604462
[TBL] [Abstract][Full Text] [Related]
15. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.
Lagou V; Scott RA; Manios Y; Chen TL; Wang G; Grammatikaki E; Kortsalioudaki C; Liarigkovinos T; Moschonis G; Roma-Giannikou E; Pitsiladis YP
Obesity (Silver Spring); 2008 Apr; 16(4):913-8. PubMed ID: 18379566
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
Namo Cury A; Longui CA; Kochi C; Calliari LE; Scalissi N; Salles JE; Neves Rocha M; Barbosa de Melo M; Rezende Melo M; Monte O
Horm Res; 2008; 70(1):36-41. PubMed ID: 18493148
[TBL] [Abstract][Full Text] [Related]
18. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.
Tönjes A; Scholz M; Loeffler M; Stumvoll M
Diabetes Care; 2006 Nov; 29(11):2489-97. PubMed ID: 17065690
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians.
Scacchi R; Pinto A; Gambina G; Rosano A; Corbo RM
Brain Res; 2007 Mar; 1139():1-5. PubMed ID: 17270153
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P
Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
